Evidence mapPaperPMID 40653749Full record

ArticleEndocrinology, diabetes & metabolism2025

Ischemic Stroke Mortality in Type 2 Diabetes in the U.S.: National Trends and Demographic Disparities From 1999 to 2019.

Muhammad Moiz Nasir, Syed Husain Farhan, Hasan Mushahid, Syeda Ayesha Shah, Muhammad Hamza Shuja, Adam Bilal Khan, Syed Hassaan Ali, Syed Ahmed Farhan, Azeem Hassan, Jawad Ahmed and 2 more

Abstract read
In one paragraph

Article in Endocrinology, diabetes & metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Muhammad Moiz NasirDepartment of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan.
Syed Husain FarhanDepartment of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan.
Hasan MushahidDepartment of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan.
Syeda Ayesha ShahDepartment of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan.
Muhammad Hamza ShujaDepartment of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan.ORCID https://orcid.org/0000-0002-3829-7298
Adam Bilal KhanDepartment of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan.
Syed Hassaan AliDepartment of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan.
Syed Ahmed FarhanDepartment of Internal Medicine, McLaren Greater Lansing Hospital, Michigan, Indiana, USA.
Azeem HassanNational Heart and Lung Institute, Imperial College London, London, UK.
Jawad AhmedDepartment of Internal Medicine, Northwest Health-Porter, Valparaiso, Indiana, USA.
Mohammad HamzaGuthrie Medical Group, Cortland, New York, USA.ORCID https://orcid.org/0000-0002-6237-0221
Javed IqbalNursing Department Communicable Diseases Centre, Hamad Medical Corporation, Doha, Qatar.ORCID https://orcid.org/0000-0003-2627-685X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe pathological changes in the lining of blood vessels associated with diabetes are a well-established risk factor for stroke, with some studies suggesting a two times increase in risk compared to non-diabetics.

methodsDeath certificates from the CDC WONDER (Centers for Disease Control and Prevention Wide-Ranging OnLine Data for Epidemiologic Research) database were examined from 1999 to 2019 for ischemic stroke-related mortality in patients with type 2 diabetes mellitus (T2DM). Annual percent change (APC) and age-adjusted mortality rates (AAMRs) per 100,000 persons were calculated and stratified by year, sex, and race/ethnicity.

resultsFrom 1999 to 2019 there were 18,135 deaths from ischemic stroke in patients with T2DM. The AAMR remained relatively constant from 0.31 in 1999 to 0.32 in 2004, gradually declining to 0.14 in 2014 (APC: -6.74), followed by a rapid increase to 0.44 in 2017 (APC: 53.11). Men showed consistently higher AAMR than women in 1999 (AAMR men: 0.34 vs. women: 0.29) and 2019 (AAMR men: 0.55 vs. women: 0.42). When comparing race, African Americans (AA) presented with a consistently higher AAMR in 1999 (AAMR AA: 0.4 vs. white: 0.29) and in 2019 (AAMR AA: 0.62 vs. white:0.44). Notably, a significant escalation in AAMR occurred from 2014 to 2019, affecting both populations; this trend reached its pinnacle in 2019 (2016 AAMR AA: 0.4 vs. white: 0.26) (2019 AAMR AA: 0.62 vs. white: 0.44).

conclusionThe findings highlight fluctuating trends in AAMRs with distinct shifts observed after 2014. Noteworthy gender and racial disparities in AAMRs were also evident. The study emphasises the need for ongoing vigilance and focused interventions to address the evolving dynamics of ischaemic stroke-related mortality in the T2DM population.

Indexed as

Diabetes Mellitus, Type 2Health Status DisparitiesIschemic StrokeAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedMortalityRisk FactorsUnited Statesdatabasediabetes mellitusobservational studystroke

Identifiers

PMID40653749
PMCPMC12256681

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.